Question 1

Has Emerico Csepanyi received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $146,997 in general payments to Emerico Csepanyi across 157 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Emerico Csepanyi did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Emerico Csepanyi come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie(2 entities)	22	$140,478
Merz North America, Inc.	52	$5,095
Pfizer	35	$522
Galderma Laboratories, L.p.	9	$201
Boehringer Ingelheim	5	$172
AstraZeneca	9	$135
Merck	7	$115
Sanofi-aventis U.S. LLC	4	$73
Johnson & Johnson	2	$53
Amarin Pharma, Inc.	2	$45
E.r. Squibb & Sons, L.L.C.	2	$43
Novo Nordisk	2	$26
Takeda Pharmaceuticals U.S.A., Inc.	5	$26
Lilly USA, LLC	1	$13

Emerico Csepanyi

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Most prescribed under Part D

Other family medicine in Cerritos